124 related articles for article (PubMed ID: 10410284)
1. Treatment of recurrent oro-genital ulceration with low doses of thalidomide.
De Wazières B; Gil H; Vuitton DA; Dupond JL
Clin Exp Rheumatol; 1999; 17(3):393. PubMed ID: 10410284
[No Abstract] [Full Text] [Related]
2. [Treatment of recurrent ulceration with low doses of thalidomide. Pilot study in 17 patients].
de Wazières B; Gil H; Magy N; Berthier S; Vuitton DA; Dupond JL
Rev Med Interne; 1999 Jul; 20(7):567-70. PubMed ID: 10434346
[TBL] [Abstract][Full Text] [Related]
3. Effect of thalidomide on orogenital ulceration.
Bowers PW; Powell RJ
Br Med J (Clin Res Ed); 1983 Sep; 287(6395):799-800. PubMed ID: 6412834
[No Abstract] [Full Text] [Related]
4. Thalidomide in severe orogenital ulceration.
Jenkins JS; Powell RJ; Allen BR; Littlewood SM; Maurice PD; Smith NJ
Lancet; 1984 Dec; 2(8417-8418):1424-6. PubMed ID: 6151044
[TBL] [Abstract][Full Text] [Related]
5. Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Behçet's disease: use of neurophysiological studies to detect thalidomide neuropathy.
Gardner-Medwin JM; Smith NJ; Powell RJ
Ann Rheum Dis; 1994 Dec; 53(12):828-32. PubMed ID: 7864692
[TBL] [Abstract][Full Text] [Related]
6. Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized, double-blind, placebo-controlled trial.
Hamuryudan V; Mat C; Saip S; Ozyazgan Y; Siva A; Yurdakul S; Zwingenberger K; Yazici H
Ann Intern Med; 1998 Mar; 128(6):443-50. PubMed ID: 9499327
[TBL] [Abstract][Full Text] [Related]
7. Infliximab treatment for severe orogenital ulceration in Behçet's disease.
Connolly M; Armstrong JS; Buckley DA
Br J Dermatol; 2005 Nov; 153(5):1073-5. PubMed ID: 16225632
[No Abstract] [Full Text] [Related]
8. [Genital ulceration].
Verraes-Derancourt S; Derancourt Ch; Janier M; Dupin N; Gerhardt P; Alcaraz I;
Ann Dermatol Venereol; 2006; 133(8-9 Pt 2):2S51-2S52. PubMed ID: 17072178
[No Abstract] [Full Text] [Related]
9. Topical granulocyte colony-stimulating factor for the treatment of oral and genital ulcers of patients with Behçet's disease.
Bacanli A; Yerebakan Dicle O; Parmaksizoglu B; Yilmaz E; Alpsoy E
J Eur Acad Dermatol Venereol; 2006 Sep; 20(8):931-5. PubMed ID: 16922940
[TBL] [Abstract][Full Text] [Related]
10. Investigation and treatment of orogenital ulceration; studies on a possible mode of action of thalidomide.
Powell RJ; Allen BR; Jenkins JS; Steele L; Hunneyball I; Maurice PD; Littlewood SM
Br J Dermatol; 1985 Jul; 113 Suppl 28():141-4. PubMed ID: 4040386
[No Abstract] [Full Text] [Related]
11. Treatment of recalcitrant orogenital ulceration of Behçet's syndrome with infliximab.
Robertson LP; Hickling P
Rheumatology (Oxford); 2001 Apr; 40(4):473-4. PubMed ID: 11312390
[No Abstract] [Full Text] [Related]
12. Thalidomide for the treatment of recalcitrant oral Crohn's disease and orofacial granulomatosis.
Hegarty A; Hodgson T; Porter S
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 May; 95(5):576-85. PubMed ID: 12738949
[TBL] [Abstract][Full Text] [Related]
13. Thalidomide: is it any wonder?
Hampshire M
Nurs Times; 1998 Aug 26-Sep 1; 94(34):14-5. PubMed ID: 9791503
[No Abstract] [Full Text] [Related]
14. Successful treatment of orogenital ulceration with transdermal nicotine patches.
Kanekura T; Kanzaki T
Br J Dermatol; 1999 Dec; 141(6):1140-1. PubMed ID: 10722271
[No Abstract] [Full Text] [Related]
15. Therapeutic Hotline. Oral allicin in the treatment of Behcet's disease through attenuating oxidative stress: A pilot study in 20 patients with mucocutaneous lesions.
Zhong J; Xian D; Xiong X; Liu J
Dermatol Ther; 2017 Jan; 30(1):. PubMed ID: 27723197
[TBL] [Abstract][Full Text] [Related]
16. Severe recurrent neurological disease in the MAGIC syndrome.
Gertner E
J Rheumatol; 2004 May; 31(5):1018-9. PubMed ID: 15124284
[No Abstract] [Full Text] [Related]
17. Apremilast for Behçet's syndrome--a phase 2, placebo-controlled study.
Hatemi G; Melikoglu M; Tunc R; Korkmaz C; Turgut Ozturk B; Mat C; Merkel PA; Calamia KT; Liu Z; Pineda L; Stevens RM; Yazici H; Yazici Y
N Engl J Med; 2015 Apr; 372(16):1510-8. PubMed ID: 25875256
[TBL] [Abstract][Full Text] [Related]
18. Dapsone use with oral-genital ulcers.
Handfield-Jones S; Allen BR; Littlewood SM
Br J Dermatol; 1985 Oct; 113(4):501. PubMed ID: 4063186
[No Abstract] [Full Text] [Related]
19. The use of sucralfate suspension in the treatment of oral and genital ulceration of Behçet disease: a randomized, placebo-controlled, double-blind study.
Alpsoy E; Er H; Durusoy C; Yilmaz E
Arch Dermatol; 1999 May; 135(5):529-32. PubMed ID: 10328192
[TBL] [Abstract][Full Text] [Related]
20. Thalidomide for the treatment of acquired immunodeficiency syndrome-associated refractory oral ulcers.
Diz Dios P; Sopeña B; Cameselle J; Butrón M; Crespo M; Ocampo A
Arch Otolaryngol Head Neck Surg; 2000 Jan; 126(1):89-92. PubMed ID: 10628719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
